Nuclear inositol 1,4,5-trisphosphate is a necessary and conserved signal for the induction of both pathological and physiological cardiomyocyte hypertrophy

Abstract It is well established that inositol 1,4,5-trisphosphate (IP3) dependent Ca 2 + signaling plays a crucial role in cardiomyocyte hypertrophy. However, it is not yet known whether nuclear IP3 represents a Ca 2 + mobilizing pathway involved in this process. The goal of the current work was to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular and cellular cardiology 2012-10, Vol.53 (4), p.475-486
Hauptverfasser: Arantes, Lilian A.M, Aguiar, Carla J, Amaya, Maria Jimena, Figueiró, Núbia C.G, Andrade, Lídia M, Rocha-Resende, Cibele, Resende, Rodrigo R, Franchini, K.G, Guatimosim, Silvia, Leite, M. Fatima
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract It is well established that inositol 1,4,5-trisphosphate (IP3) dependent Ca 2 + signaling plays a crucial role in cardiomyocyte hypertrophy. However, it is not yet known whether nuclear IP3 represents a Ca 2 + mobilizing pathway involved in this process. The goal of the current work was to investigate the specific role of nuclear IP3 in cardiomyocyte hypertrophic response. In this work, we used an adenovirus construct that selectively buffers IP3 in the nuclear region of neonatal cardiomyocytes. We showed for the first time that nuclear IP3 mediates endothelin-1 (ET-1) induced hypertrophy. We also found that both calcineurin (Cn)/nuclear factor of activated T Cells (NFAT) and histone deacetylase-5 (HDAC5) pathways require nuclear IP3 to mediate pathological cardiomyocyte growth. Additionally, we found that nuclear IP3 buffering inhibited insulin-like growth factor-1 (IGF-1) induced hypertrophy and prevented reexpression of fetal gene program. Together, these results demonstrated that nuclear IP3 is an essential and a conserved signal for both pathological and physiological forms of cardiomyocyte hypertrophy.
ISSN:0022-2828
1095-8584
DOI:10.1016/j.yjmcc.2012.06.017